FIELD: affine ligands. SUBSTANCE: solution of chitosan salt is mixed with organic or mineral acid at pH 6.0-7.5 and then mixed with sodium dextran sulfate solution. Solvent water or 2-6 M aqueous urea solution. Mixture is kept up to pH 7.5-9.0. Molar ratio of chitosan salt and dextran sulfate is 1: (2-12), ratio of molecular mass of chitosan salt and sodium dextran sulfate is at the range 0.02-0.4. Product is used for binding atherogenic lipoproteins from blood and can be used in medicine. EFFECT: improved method of complex preparing. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADSORBENTS FOR EXTRACTING ATHEROGENIC LIPOPROTEINS FROM BIOLOGICAL LIQUIDS | 1992 |
|
RU2029565C1 |
| METHOD OF SULFATED CHITOSAN PREPARING | 1992 |
|
RU2048475C1 |
| ADSORBENT FOR EXTRACTING ATHEROGENIC LIPOPROTEINS FROM BIOLOGICAL LIQUIDS | 1992 |
|
RU2029564C1 |
| METHOD OF SULFATED CHITOSAN PREPARING | 1992 |
|
RU2048474C1 |
| INTERPOLYMER CARRIER FOR ORAL SYSTEMS OF CONTROLLED DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS | 2018 |
|
RU2725879C2 |
| METHOD FOR PRODUCING CARRIER OF BIOLOGICALLY ACTIVE COMPOUNDS OF INTERPOLYELECTROLYTE COMPLEX | 2009 |
|
RU2445118C2 |
| PROCESS FOR MANUFACTURE OF LONG-ACTING QUINIDINE SULFATE TABLETS | 1992 |
|
RU2036641C1 |
| METHOD OF PREPARING CARBOXYL-CONTAINING CHITOSAN DERIVATIVES | 0 |
|
SU802290A1 |
| PROCESS FOR MANUFACTURE OF LONG-ACTING BRONCHOLITHIC MEDICINAL COMPOSITION BASED ON THEOPHYLLINE | 1992 |
|
RU2036642C1 |
| METHOD FOR SEPARATION AND QUANTITATIVE DETERMINATION OF MULTIPLY MODIFIED LOW-DENSITY LIPOPROTEINS | 2015 |
|
RU2592238C1 |
